Trial Profile
Phase II Study on Axitinib in Advanced VEGFR and/or PDGFR Solitary Fibrous Tumor
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2021
Price :
$35
*
At a glance
- Drugs Axitinib (Primary)
- Indications Solitary-fibrous-tumour
- Focus Therapeutic Use
- 22 Sep 2021 Status changed from not yet recruiting to completed.
- 05 Dec 2018 Results published in the European Journal of Cancer
- 20 May 2014 New trial record